Pharma channel feed – Endpoints News

Pharma channel feed

Corrected: Lilly upped its offer for Morphic by $11 per share, documents show

10 months ago

Q&A: How argenx’s CEO plans to create a sequel to Vyvgart (and beat the IRA)

10 months ago

Novartis CEO: Trying to crack obesity market with another first-gen agent is 'not a prudent approach'

10 months ago

GoodRx launches discount for Boehringer Ingelheim's Humira biosimilar

10 months ago

Novartis settles in to new normal two years after big reorg, even as fine-tuning continues

10 months ago

Merck asks DC federal court for IRA decision 'as soon as practicable'

10 months ago

J&J has its final offer in hand from the government over IRA pricing

10 months ago

Big three PBMs will testify before Congress next week, following FTC report

10 months ago

Genentech parts ways with Relay Therapeutics on SHP2 after other pharma exits

10 months ago

After a handful of stumbles, argenx doubles down on pipeline-in-a-product strategy as it pitches investors

10 months ago

Large group of state attorneys general backs Oregon drug price transparency law

10 months ago

Federal judge dismisses Hawaii’s lawsuit against top three PBMs

10 months ago

AstraZeneca criticizes CMS guidance in appeal over price negotiations

10 months ago

Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C

10 months ago

Vertex takes federal government to court over Casgevy fertility treatment program

10 months ago

Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab

10 months ago

J&J calls proposed class action talc suit 'meritless' as settlement vote deadline nears

10 months ago

EMA warns patients to tell doctors about GLP-1 usage before surgery

10 months ago

GSK HQ officially returns to central London after decades in city’s suburbs

10 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

11 months ago

Indivior axes schizophrenia drug and shrinks revenue guidance

11 months ago

AbbVie asks Supreme Court to reconsider ruling on attorney-client communication

11 months ago

Senate unanimously passes bipartisan pharma patent bill

11 months ago

AbbVie's Humira is still on top, but biosimilars are chipping away at its dominance

11 months ago

First page Previous page 46 47 484950 51 52 Next page Last page